Statistical Validation of Surrogate Endpoints: Problems and Proposals-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Statistical Validation of Surrogate Endpoints: Problems and Proposals

Published:2000-04 Issue:2 Volume:34 Page:447-454
ISSN:0092-8615
Container-title:Drug Information Journal
language:en
Short-container-title:Drug Information J

Author:

Buyse Marc,Molenberghs Geert,Burzykowski Tomasz,Renard Didier,Geys Helena

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Public Health, Environmental and Occupational Health,Drug Guides,Pharmacology (nursing)

Link

http://link.springer.com/content/pdf/10.1177/009286150003400213.pdf

Reference20 articles.

1. Ellenberg SS, Hamilton JM. Surrogate endpoints in clinical trials: cancer. Stat Med. 1989;8:405–413.

2. Prentice RL. Surrogate endpoints in clinical trials: definitions and operational criteria. Stat Med. 1989;8:431–440.

3. Buyse M, Molenberghs G. The validation of surrogate endpoints in randomized experiments. Biometrics. 1998;54:1014–1029.

4. Freedman LS, Graubard BI, Schatzkin A. Statistical validation of intermediate endpoints for chronic diseases. Stat Med. 1992;11:167–178.

5. Lin DY, Fischl MA, Schoenfeld DA. Evaluating the role of CD4-lymphocyte change as a surrogate end-point in HIV clinical trials. Stat Med. 1993;12:835–842.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The importance of post-discharge surgical site infection surveillance: an exploration of surrogate outcome validity in a global randomised controlled trial (FALCON);The Lancet Global Health;2023-08

2. Biomarker Qualification: Toward a Multiple Stakeholder Framework for Biomarker Development, Regulatory Acceptance, and Utilization;Clinical Pharmacology & Therapeutics;2015-06-06

3. Medical Statistics;The Textbook of Pharmaceutical Medicine;2013-04-25

4. Accommodating missingness when assessing surrogacy via principal stratification;Clinical Trials;2013-04-03

5. Quantification of PFS Effect for Accelerated Approval of Oncology Drugs;Springer Proceedings in Mathematics & Statistics;2013

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3